Company · founded 2011
Annexon Biosciences (United States)
South San Francisco, United States · annexonbio.com
- Citations, last 5 years
- 890
- Works, last 5 years
- 75
- h-index
- 68
- Scientists listed
- 11
- Grants since 2016
- 2
Grants received
2021–2024 · grant · ALSRP
The Effect of ANX005, an Anti-C1q Antibody, on Biomarkers of Target and Pathway Engagement and Neurodegeneration in ALS Patients
Benjamin Hoehn · Annexon Biosciences (United States) · funded by Congressionally Directed Medical Research Programs
2016–2017 · research · R44
Development of novel inhibitors of C1q for the treatment of Neurodegenerative diseases
Sethu Sankaranarayanan · Annexon Biosciences (United States) · funded by National Institutes of Health